LCT and hepatocellular carcinoma: The Lac-MSNs were demonstrated to specifically target ASGPR-positive HepG2 and SMMC7721 cells, and their internalization into hepatoma cells is an energy-consuming process and predominated by clathrin-mediated endocytosis.